BioScrip Pharmacy (NY), Inc.
FDA inspection history across 2 sites, 2014
- 1
- Response
- 1
- Form 483
Every document, by year
- Response
- Form 483
2014: one 483 response and one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2014One 483 response and one Form 483, at Jamaica, New York and Lake Success, New York.
Cited most
Across all BioScrip Pharmacy (NY) observations on file
- 21 CFR 211.42Design and construction features4
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.167Special testing requirements1
The complete BioScrip Pharmacy (NY) file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Jamaica, New York
One 483 response · 2014
Latest: Response, Oct 10, 2014 →Lake Success, New York
One Form 483 · 2014 · 9 observations
Latest: Form 483, Sep 19, 2014 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2014-10-10 | Response 483 response | Jamaica, New York | — | $199 |
| 2014-09-19 | 483 Form 483 | Lake Success, New York | 9 | $99 |
Investigators on these documents
FEI number 3011022663 · most recent document Oct 10, 2014
About BioScrip Pharmacy (NY), Inc.
How many FDA Form 483s has BioScrip Pharmacy (NY), Inc. received?
FDA Intel has 1 Form 483 on file for BioScrip Pharmacy (NY), Inc.; the most recent is dated Sep 19, 2014.
When was BioScrip Pharmacy (NY), Inc. last inspected by FDA?
The most recent FDA inspection document on file for BioScrip Pharmacy (NY), Inc. is a Form 483 dated Sep 19, 2014, for the site in Lake Success, New York.
What did FDA cite at BioScrip Pharmacy (NY), Inc.?
The regulations cited most in the observations on file for BioScrip Pharmacy (NY), Inc. are 21 CFR 211.42 (Design and construction features), 4 times; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time.